Design, synthesis and biological evaluation of novel ferrocene-pyrazole derivatives containing nitric oxide donors as COX-2 inhibitors for cancer therapy-Reference-Cited by-同舟云学术

Design, synthesis and biological evaluation of novel ferrocene-pyrazole derivatives containing nitric oxide donors as COX-2 inhibitors for cancer therapy

Published:2018-09 Issue: Volume:157 Page:909-924
ISSN:0223-5234
Container-title:European Journal of Medicinal Chemistry
language:en
Short-container-title:European Journal of Medicinal Chemistry

Author:

Ren Shen-Zhen,Wang Zhong-Chang,Zhu Dan,Zhu Xiao-Hua,Shen Fa-Qian,Wu Song-Yu,Chen Jin-Jin,Xu Chen,Zhu Hai-Liang^ORCID

Funder

National Natural Science Foundation of China

Public Science and Technology Research Fund Project of Ocean

State Key Laboratory of Pharmaceutical Biotechnology of Nanjing University

Publisher

Elsevier BV

Subject

Organic Chemistry,Drug Discovery,Pharmacology,General Medicine

Reference31 articles.

1. Why there are two cyclooxygenase isozymes;Smith;J. Clin. Invest.,2001

2. COX-2 as a target for cancer chemotherapy;Ghosh;Pharmacol. Rep.,2010

3. Synthesis, biological evaluation and molecular modeling study of pyrazole derivatives as selective COX-2 inhibitors and anti-inflammatory agents;Tewari;Bioorg. Chem.,2014

4. Toward an optimal docking and free energy calculation scheme in ligand design with application to COX-1 inhibitors;Shamsudin;J. Chem. Inf. Model.,2014

5. COX-3, a cyclooxygenase-1 variant inhibited by acetaminophen and other analgesic/antipyretic drugs: cloning, structure, and expression;Chandrasekharan;Proc. Natl. Acad. Sci. U.S.A.,2002

Cited by 55 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Overcoming Challenges in O‐Nitration: Selective Alcohol Nitration Deploying N,6‐Dinitrosaccharin and Lewis Acid Catalysis;Angewandte Chemie International Edition;2024-08-23

2. Overcoming Challenges in O‐Nitration: Selective Alcohol Nitration Deploying N,6‐Dinitrosaccharin and Lewis Acid Catalysis;Angewandte Chemie;2024-08-23

3. Selective COX-2 inhibitors as anticancer agents: a patent review (2018-2023);Expert Opinion on Therapeutic Patents;2024-07-03

4. Ferrocenyl Azoles: Versatile N‐Containing Heterocycles and their Anticancer Activities;The Chemical Record;2024-07

5. 1,3,5-Triaza-7-phosphaadamantane and Cyclohexyl Groups Impart to Di-Iron(I) Complex Aqueous Solubility and Stability, and Prominent Anticancer Activity in Cellular and Animal Models;Journal of Medicinal Chemistry;2024-07-01